FDA NDC Directory · JSON-LD · Markdown

Thiotepa

NDC 25021-246 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA209150
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRACAVITARY INTRAVENOUS INTRAVESICAL
Active ingredientsTHIOTEPA (15 mg/1.5mL)
Marketing started20180615
Package count1

External sources

Source: openFDA. Public-domain (CC0).